NDA 21-515

 

Wellbutrin (bupropion hydrochloride)

Extended Release Tablets

 

 

GlaxoSmithKline, Inc

 

 

Sherita D. McLamore, Ph.D.

Division of Neuropharmacological Drug Products

HFD-120

 

 

 

 

 

Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page